SANTA CLARA, Calif.,
March 7, 2011 /PRNewswire/ --
Samplify Systems, Inc., a leading provider of technology,
semiconductors and sub-systems for medical, industrial, wireless,
and scientific markets, has completed its Series B round of
funding. The $11.2M of capital
enables the company to fund its rapid growth in its existing
markets, and offers flexibility to expand into new markets.
Participating in the round are Integrated Device Technology,
Inc. (Nasdaq: IDTI), Charles River Ventures, Formative Ventures and
Schlumberger (NYSE: SLB). The company also announced that
Ginger Hildebrand, Software
Governance Manager for Schlumberger, will take a board position at
Samplify.
(Logo:
http://photos.prnewswire.com/prnh/20080411/AQF028LOGO)
Tom Sparkman, CEO of Samplify,
remarks, “Samplify has experienced tremendous growth over the last
year, driven by the success of new products for its core ultrasound
and wireless markets. This funding round fully finances
growth in the company’s core markets, and gives us the flexibility
to take Samplify’s technology into new markets through our
strategic partners.”
Bruce Sachs, General Partner of
Charles River Ventures, adds, “With this round of funding, we are
pleased to see Samplify secure a path to self-sustain its business
model for the company’s technology and solutions. For
Samplify to be among the very few technology companies to complete
a round in this economic climate is a testament to its compelling
technology, solutions, market traction, and the strategic value the
company brings to its partners.”
“With this investment, we are looking forward to deeper
collaboration with Samplify,” comments Ted
Tewksbury, CEO of IDT.
Samplify has achieved many milestones in the past year
including:
- Introduction of its novel AutoFocus™ beamforming technology for
ultrasound applications for which the company was awarded
Electronic Design’s prestigious “2010 Best Design” award for
medical product. The beamforming technology is available as a
complete development kit, making Samplify the only semiconductor
company that can demonstrate the image quality of its solutions
“out-of-the-box.”
- Introduction of the first ultrasound machines built around the
company’s award-winning analog front-end solutions at the China
Medical Equipment Fair in Shenyang,
China. Samplify’s analog front-end solutions include
the SAM1600, the world’s only true 16-channel ADC for ultrasound
applications, and the SMM9132 and SMM9133, the only analog-front
end signal chain modules in a compact 32 channel SO-DIMM form
factor.
- Introduction of its Prism IQ™ signal compression technology
which achieves virtually lossless EVM performance at better than
2:1 compression for LTE, WiMAX, TD-SCDMA, and W-CDMA baseband
signals within wireless base stations using the Common Public Radio
Interface (CPRI) specification, or the Open Base Station
Architecture Initiative (OBSAI).
Woodside Capital Partners acted as advisor to Samplify during
the fundraising process.
About Samplify Systems:
Samplify is a provider technology, semiconductors, and solutions
for the medical imaging, wireless infrastructure, and industrial
markets. Headquartered in Santa Clara,
CA, Samplify’s signal processing and mixed-signal
technology, including its AutoFocus™ beamformer and the SAM1600
family of compressing ADCs, have won multiple industry awards for
innovation. Additional information about Samplify’s products
can be found at www.samplify.com/ultrasound, and
www.samplify.com/wireless.
SOURCE Samplify Systems, Inc.